The investment bank Jefferies had been running its healthcare conference in London for 14 years as a reasonably intimate ...

Cornerstone Robotics secured about $200 million in its second round of financing this year, which the Hong Kong-based company ...

Roche has reported another phase 3 win for its oral selective estrogen receptor degrader (SERD). Success at a planned interim ...

Through a collaboration with Edwards Lifesciences, Philips is rolling out new artificial intelligence tools designed to ...

Genmab has shed another antibody-drug conjugate from its April 2024 acquisition of ProfoundBio. | Genmab has shed another ...

After laying off most of its staff and partnering away its phase 3 cancer asset earlier this year, precision oncology outfit ...

Johnson & Johnson is paying $3.05 billion to acquire Halda Therapeutics, obtaining a novel cell death platform while ...

The startup incubator MedTech Innovator only launched in 2013, but it has had an immense impact on the industry. | Three MedTech Innovator startups showed off their diagnostic tech at the American ...

Nxera Pharma has outlined plans to lay off 15% of its staff and prioritize its pipeline as part of a push to clear its path ...

Artios Pharma collected $115 million from an oversubscribed series D that will support its growing ambitions for its pipeline ...

A San Diego biotech has set out to solve the formula for best-in-class antibody-drug conjugates, raising $120 million with ...

Bayer has built a home for Chinese biopharma companies. Located in Beijing, the Bayer E-Town Open Innovation Center will ...